GGrantIndex
Sort

85,873 grants matching alzheimers

Clinical/Imaging Core

$974,542
Sandra Weintraub · University Of Chicago · U19 · FY2024 · AG

Clinical Core

$974,231
Douglas R Galasko · University Of California, San Diego · P50 · FY2018 · AG

Core A - Administrative Core

$974,087
Gil Dan Rabinovici · University Of California, San Francisco · P30 · FY2024 · AG

SYNAPSINS, SYNAPTOGENESIS AND ALZHEIMERS DISEASE

$974,084
Rockefeller University · P01 · FY2002 · AG

Genetic Epidemiology of Coronary Artery Disease

$973,920
University Of Michigan At Ann Arbor · R01 · FY2003 · HL

Dietary protection against APOE4 phenotypes in aging and Alzheimer's

$973,858
Christian J Pike · University Of Southern California · R01 · FY2025 · AG

UAS-CLEAR: A new nationally representative longitudinal study of caregiving experiences and well-being across the lifecourse

$973,820
Kira S Birditt · University Of Michigan At Ann Arbor · R01 · FY2023 · AG

PREVENTION OF ALZHEIMER'S BY VITAMIN E AND SELENIUM

$973,801
University Of Kentucky · R01 · FY2003 · AG

Epidemiology of Aging and Dementia - Autopsy Research

$973,680
Lon Ray White · Kuakini Medical Center · R01 · FY2007 · AG

Core F: Biomarker Core

$973,609
Gene E Alexander · Arizona State University-Tempe Campus · P30 · FY2021 · AG

ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System

$973,545
Cui Tao · Mayo Clinic Jacksonville · R01 · FY2025 · AG

"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"

$973,393
Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG

Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias

$973,322
Mark W Albers · Massachusetts General Hospital · R01 · FY2024 · AG

Post Traumatic Stress Disorder and Accelerated Aging in Women

$973,093
Karestan C Koenen · Harvard School Of Public Health · R01 · FY2021 · MH

Development of patented tricyclic pyrones molecules for the treatment of Alzheimer’s Disease

$973,076
Xinmin Simon Xie · Afasci, Inc. · R44 · FY2017 · AG

Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses

$972,873
Fang Yu · Arizona State University-Tempe Campus · R01 · FY2023 · AG

Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related Dementias

$972,457
Michael Alosco · Boston University Medical Campus · R01 · FY2025 · NS

The influence of familial social context on risk dissemination and coping

$972,437
Laura M Koehly · National Human Genome Research Institute · ZIA · FY2011 · HG

Longitudinal imaging of microglial activation in different clinical variants of Alzheimer's disease

$972,355
William Charles Kreisl · Columbia University Health Sciences · R01 · FY2020 · AG

Discovering Centrally Linked Peripheral Molecular Signatures of Alzheimer's Disease

$972,232
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U19 · FY2024 · AG

Admin Core

$971,960
Angela L. Jefferson · Vanderbilt University Medical Center · P20 · FY2022 · AG

Alzheimer's Disease Core Center

$971,924
Northwestern University · P30 · FY2001 · AG

Neuroprotective role of GLP-1 receptor agonists

$971,839
Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG

Regulation of Neuronal Excitability

$971,729
Baylor College Of Medicine · P01 · FY2004 · NS

Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy

$971,719
Nadia N Laack · Mayo Clinic Rochester · U01 · FY2022 · CA